CA2199131C - Hybrides vectoriels retroviraux et leur utilisation pour le transfert de genes - Google Patents

Hybrides vectoriels retroviraux et leur utilisation pour le transfert de genes Download PDF

Info

Publication number
CA2199131C
CA2199131C CA002199131A CA2199131A CA2199131C CA 2199131 C CA2199131 C CA 2199131C CA 002199131 A CA002199131 A CA 002199131A CA 2199131 A CA2199131 A CA 2199131A CA 2199131 C CA2199131 C CA 2199131C
Authority
CA
Canada
Prior art keywords
virus
region
mesv
binding site
ltr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002199131A
Other languages
English (en)
Other versions
CA2199131A1 (fr
Inventor
Christopher Baum
Carol Stocking-Harbers
Wolfram Ostertag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vision 7 GmbH
Original Assignee
Vision 7 GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19503952A external-priority patent/DE19503952A1/de
Application filed by Vision 7 GmbH filed Critical Vision 7 GmbH
Priority claimed from PCT/EP1995/003175 external-priority patent/WO1996007747A1/fr
Publication of CA2199131A1 publication Critical patent/CA2199131A1/fr
Application granted granted Critical
Publication of CA2199131C publication Critical patent/CA2199131C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Hybrides vectoriels rétroviraux à défauts de réplication, caractérisés en ce qu'ils contiennent a) dans la région leader, comme région U5 et/ou comme site de liaison amorce tRNA, la région U5 et/ou le site de liaison amorce tRNA de MESV et, b) comme régions U3 et R en 3'-LTR, les régions U3 et R d'un virus de leucémie murine Friend (F-MuLV). Les hybrides selon l'invention sont particulièrement appropriés pour un transfert efficace de gènes dans des cellules souches hématopoïétiques.
CA002199131A 1994-09-08 1995-08-10 Hybrides vectoriels retroviraux et leur utilisation pour le transfert de genes Expired - Fee Related CA2199131C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DEP4431973.8 1994-09-08
DE4431973 1994-09-08
DE19503952.1 1995-02-07
DE19503952A DE19503952A1 (de) 1994-09-08 1995-02-07 Retrovirale Vektorhybride und deren Verwendung zum Gentransfer
PCT/EP1995/003175 WO1996007747A1 (fr) 1994-09-08 1995-08-10 Hybrides vectoriels retroviraux et leur utilisation pour le transfert de genes

Publications (2)

Publication Number Publication Date
CA2199131A1 CA2199131A1 (fr) 1996-03-14
CA2199131C true CA2199131C (fr) 2007-04-10

Family

ID=38007181

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002199131A Expired - Fee Related CA2199131C (fr) 1994-09-08 1995-08-10 Hybrides vectoriels retroviraux et leur utilisation pour le transfert de genes

Country Status (1)

Country Link
CA (1) CA2199131C (fr)

Also Published As

Publication number Publication date
CA2199131A1 (fr) 1996-03-14

Similar Documents

Publication Publication Date Title
US5714353A (en) Safe vectors for gene therapy
US6949242B2 (en) Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells
US5858744A (en) Retroviral vector hybrids and the use thereof for gene transfer
AU650085B2 (en) Bifunctional selectable fusion genes
US6027722A (en) Vectors for gene transfer
US6013517A (en) Crossless retroviral vectors
US5747323A (en) Retroviral vectors comprising a VL30-derived psi region
CA2160034C (fr) Vecteurs retroviraux a base du virus de la leucemie du gibbon
JP2001502903A (ja) レンチウィルスベクター
JPH09500783A (ja) シトシンデアミナーゼ（ｃｄ）遺伝子に基づく二機能性選択融合遺伝子
EP0953052A1 (fr) Vecteurs retroviraux sans croisement
EP0688358A1 (fr) Vecteurs ameliores en therapie genique
US5710037A (en) Retroviral vector particles
US5698446A (en) Methods and compositions for inhibiting production of replication competent virus
Beck-Engeser et al. Retroviral vectors related to the myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells
Couture et al. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression
EP2669378A1 (fr) Système de gène suicide du cytochrome P450
JP2002542834A (ja) レトロウイルスベクターでのｉｒｅｓ転写カセットからの異種遺伝子群の発現
WO1996035798A1 (fr) Ameliorations apportees a des vecteurs retroviraux, appropries en particulier pour la therapie genique
US5631162A (en) Retroviral vectors for transducing β-globin gene and β-locus control region derivatives
JPH11507244A (ja) Ｓｒｖ−３エンベロープ糖タンパク質配列で偽型化したレトロウイルスベクター
EP0845041A1 (fr) Vecteurs a auto-suppression pour therapie genique
Kaptein et al. Expression pattern of CD2 locus control region containing retroviral vectors in hemopoietic cells in vitro and in vivo
IL116216A (en) Eukaryotic cell lineages for recombinant viral retroviral RNA storage, using trans-expression vectors used to complete the trans
KR20010013332A (fr) Particules de vecteur de retrovirus produites dans un systeme d'expression de baculovirus

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed